Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Jun 11, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2018 PForm 4 → | Jun 8, 6:34 pm EDT | Versartis, Inc.VSAR | Srinivas AkkarajuDirector | 1,055,485 | $1.81 | $1,914,709 | 2,629,536 | +67.1% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 7:09 am EDT | ADMA BIOLOGICS, INC.ADMA | Adam S GrossmanPresident and CEO, Director | 73,222 | $4.78 | $350,001 | 796,301 | +10.1% | plan? |
| Jun 6, 2018 PForm 4 → | Jun 8, 5:29 pm EDT | Pingtan Marine Enterprise Ltd.PME | Xinrong ZhuoCEO, Director, 10% Owner | 100,000 | $3.00 | $300,400 | 45,172,355 | +0.22% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 7:10 am EDT | ADMA BIOLOGICS, INC.ADMA | Jerrold B GrossmanDirector | 52,302 | $4.78 | $250,004 | 31,381 | — | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 7:09 am EDT | ADMA BIOLOGICS, INC.ADMA | Lawrence P. GuiheenDirector | 20,000 | $4.78 | $95,600 | 25,000 | +400% | plan? |
| Jun 7, 2018 PForm 4 → | Jun 8, 9:45 pm EDT | SECOND SIGHT MEDICAL PRODUCTS INCEYES | Gregg WilliamsDirector, 10% Owner | 46,862 | $1.84 | $86,052 | 26,443,329 | +0.18% | plan? |
| Jun 6, 2018 PForm 4 → | Jun 8, 8:18 pm EDT | Hunt Companies Finance Trust, Inc.HCFT | James Christopher HuntDirector | 22,500 | $3.51 | $78,900 | 75,000 | +42.9% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 8:48 am EDT | CATALYST PHARMACEUTICALS, INC.CPRX | Donald A DenkhausDirector | 20,000 | $3.41 | $68,200 | 140,000 | +16.7% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 8, 4:08 pm EDT | STRATA Skin Sciences, Inc.SSKN | LuAnn ViaDirector | 25,000 | $2.14 | $53,500 | 25,000 | — | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 7:08 am EDT | ADMA BIOLOGICS, INC.ADMA | Eric I RichmanDirector | 5,230 | $4.78 | $24,999 | 36,530 | +16.7% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 7:08 am EDT | ADMA BIOLOGICS, INC.ADMA | Brian LenzVP, CFO | 5,000 | $4.78 | $23,900 | 20,000 | +33.3% | plan? |
| Jun 4, 2018 PForm 4 → | Jun 8, 5:32 pm EDT | Vaxart, Inc.VXRT | Michael J. FinneyDirector | 5,000 | $3.40 | $17,021 | 233,978 | +2.18% | plan? late |
| Apr 3, 2015 PForm 4 → | Jun 11, 2018, 11:31 am EDT | Nascent Biotech Inc.NBIO | Douglas John KarasDirector | 10,000 | $1.00 | $10,000 | 10,000 | — | plan? late |
| Jun 6, 2018 PForm 4 → | Jun 8, 8:17 pm EDT | Hunt Companies Finance Trust, Inc.HCFT | Neil A. CumminsDirector | 2,637 | $3.40 | $8,959 | 29,294 | +9.89% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 6:03 am EDT | Trovagene, Inc.TROV | Stanley TennantDirector | 10,000 | $0.80 | $8,000 | 236,061 | +4.42% | plan? amended |
| Jun 8, 2018 PForm 4 → | Jun 11, 6:03 am EDT | Trovagene, Inc.TROV | John P BrancaccioDirector | 10,000 | $0.80 | $8,000 | 53,167 | +23.2% | plan? amended |
| Jun 8, 2018 PForm 4/A → | Jun 11, 12:02 pm EDT | RETRACTABLE TECHNOLOGIES INCRVP | Thomas J ShawPresident and CEO, Director, 10% Owner | 4,900 | $0.85 | $4,165 | 13,474,027 | +0.04% | plan? |
| Jun 8, 2018 PForm 4 → | Jun 8, 4:23 pm EDT | RETRACTABLE TECHNOLOGIES INCRVP | Thomas J ShawPresident and CEO, Director, 10% Owner | 4,500 | $0.85 | $3,825 | 13,473,627 | +0.03% | plan? amended |
| Jun 7, 2018 PForm 4 → | Jun 8, 4:26 pm EDT | CATALYST PHARMACEUTICALS, INC.CPRX | Charles B O'KeeffeDirector | 1,000 | $3.35 | $3,352 | 523,376 | +0.19% | plan? |
| May 30, 2014 PForm 4/A → | Jun 11, 2018, 6:25 am EDT | INCEPTION MINING INC.IMII | Trent D'AmbrosioCEO and CFO, Director | 5,300 | $0.5594 | $2,965 | 702,244 | +0.76% | plan? |
| Jun 7, 2018 PForm 4 → | Jun 8, 6:47 pm EDT | REALNETWORKS INCRNWK | Robert GlaserChairman and CEO, Director, 10% Owner | 622 | $3.50 | $2,177 | 13,138,989 | +0.00% | plan? |
| Jun 7, 2018 PForm 4 → | Jun 11, 9:32 am EDT | 180 DEGREE CAPITAL CORP. /NY/TURN | Kevin RendinoChairman and CEO, Director | 310 | $2.17 | $673 | 466,769 | +0.07% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.